References
Selmi C, Gershwin ME (2014) Diagnosis and classification of reactive arthritis. Autoimmun Rev 13:546–549
Soy M, Keser G, Atagündüz P, Tabak F, Atagündüz I, Kayhan S (2020) Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol 39:2085–2094
Ono K, Kishimoto M, Shimasaki T, Uchida H, Kurai D, Deshpande GA et al (2020) Reactive arthritis after COVID-19 infection. RMD Open 6:e001350. https://doi.org/10.1136/rmdopen-2020-001350
Ahmed S, Gasparyan AY, Zimba O (2021) Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic. Rheumatol Int 41:243–256. https://doi.org/10.1007/ s00296-020-04764-5
Gibson M, Sampat K, Coakley G (2020) A self-limiting symmetrical polyarthritis following COVID-19 infection. Rheumatol Adv Pract. https://doi.org/10.1093/rap/rkaa052.014
Funding
Nil.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ganta, S.R., Garg, A., Shah, K. et al. Post Covid-19 Reactive Arthritis in Two Stem Cell Transplant Recipients. Indian J Hematol Blood Transfus 39, 154–155 (2023). https://doi.org/10.1007/s12288-022-01549-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-022-01549-7